Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome H Reichman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Houston Law Review|March 23, 2011
INTELLECTUAL PROPERTY IN THE TWENTY-FIRST CENTURY: WILL THE DEVELOPING COUNTRIES LEAD OR FOLLOW?Jerome H Reichman
Marquette Intellectual Property Law Review|May 1, 2010
RETHINKING THE ROLE OF CLINICAL TRIAL DATA IN INTERNATIONAL INTELLECTUAL PROPERTY LAW: THE CASE FOR A PUBLIC GOODS APPROACHJerome H Reichman
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|June 5, 2009
Comment: compulsory licensing of patented pharmaceutical inventions: evaluating the optionsJerome H Reichman
Science (New York, N.Y.)|December 15, 2015
DATA ACCESS. Sharing by design: Data and decentralized commonsJorge L Contreras, Jerome H Reichman
Minnesota Law Review|March 19, 2014
When Copyright Law and Science Collide: Empowering Digitally Integrated Research Methods on a Global ScaleJerome H Reichman, Ruth L Okediji
Yale Journal of Health Policy, Law, and Ethics|June 21, 2008
Pathways across the valley of death: novel intellectual property strategies for accelerated drug discoveryArti K Rai, Jerome H Reichman, Paul F Uhlir, et al.
Plos Biology|October 31, 2008
Is Bayh-Dole good for developing countries? Lessons from the US experienceAnthony D So, Bhaven N Sampat, Arti K Rai, et al.
Mbio|August 17, 2017
The U.S. Culture Collection Network Responding to the Requirements of the Nagoya Protocol on Access and Benefit SharingKevin McCluskey, Katharine B Barker, Hazel A Barton, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Houston Law Review|March 23, 2011
INTELLECTUAL PROPERTY IN THE TWENTY-FIRST CENTURY: WILL THE DEVELOPING COUNTRIES LEAD OR FOLLOW?Jerome H Reichman
Marquette Intellectual Property Law Review|May 1, 2010
RETHINKING THE ROLE OF CLINICAL TRIAL DATA IN INTERNATIONAL INTELLECTUAL PROPERTY LAW: THE CASE FOR A PUBLIC GOODS APPROACHJerome H Reichman
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|June 5, 2009
Comment: compulsory licensing of patented pharmaceutical inventions: evaluating the optionsJerome H Reichman
Science (New York, N.Y.)|December 15, 2015
DATA ACCESS. Sharing by design: Data and decentralized commonsJorge L Contreras, Jerome H Reichman
Minnesota Law Review|March 19, 2014
When Copyright Law and Science Collide: Empowering Digitally Integrated Research Methods on a Global ScaleJerome H Reichman, Ruth L Okediji
Yale Journal of Health Policy, Law, and Ethics|June 21, 2008
Pathways across the valley of death: novel intellectual property strategies for accelerated drug discoveryArti K Rai, Jerome H Reichman, Paul F Uhlir, et al.
Plos Biology|October 31, 2008
Is Bayh-Dole good for developing countries? Lessons from the US experienceAnthony D So, Bhaven N Sampat, Arti K Rai, et al.
Mbio|August 17, 2017
The U.S. Culture Collection Network Responding to the Requirements of the Nagoya Protocol on Access and Benefit SharingKevin McCluskey, Katharine B Barker, Hazel A Barton, et al.
Pageof 1